Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 6 of 6 entries
Sorted by: Best Match Show Resources per page
Exposure to environmental microbiota explains persistent abdominal pain and irritable bowel syndrome after a major flood.

Gut pathogens

Yusof N, Hamid N, Ma ZF, Lawenko RM, Wan Mohammad WMZ, Collins DA, Liong MT, Odamaki T, Xiao J, Lee YY.
PMID: 29255490
Gut Pathog. 2017 Dec 14;9:75. doi: 10.1186/s13099-017-0224-7. eCollection 2017.

BACKGROUND: After an environmental disaster, the affected community is at increased risk for persistent abdominal pain but mechanisms are unclear. Therefore, our study aimed to determine association between abdominal pain and poor water, sanitation and hygiene (WaSH) practices, and...

Cite
Yusof N, Hamid N, Ma ZF, et al. Exposure to environmental microbiota explains persistent abdominal pain and irritable bowel syndrome after a major flood. Gut Pathog. 2017;9:75doi: 10.1186/s13099-017-0224-7.
Yusof, N., Hamid, N., Ma, Z. F., Lawenko, R. M., Wan Mohammad, W. M. Z., Collins, D. A., Liong, M. T., Odamaki, T., Xiao, J., & Lee, Y. Y. (2017). Exposure to environmental microbiota explains persistent abdominal pain and irritable bowel syndrome after a major flood. Gut pathogens, 975. https://doi.org/10.1186/s13099-017-0224-7
Yusof, NurFadhilah, et al. "Exposure to environmental microbiota explains persistent abdominal pain and irritable bowel syndrome after a major flood." Gut pathogens vol. 9 (2017): 75. doi: https://doi.org/10.1186/s13099-017-0224-7
Yusof N, Hamid N, Ma ZF, Lawenko RM, Wan Mohammad WMZ, Collins DA, Liong MT, Odamaki T, Xiao J, Lee YY. Exposure to environmental microbiota explains persistent abdominal pain and irritable bowel syndrome after a major flood. Gut Pathog. 2017 Dec 14;9:75. doi: 10.1186/s13099-017-0224-7. eCollection 2017. PMID: 29255490; PMCID: PMC5729606.
Copy Download .nbib Format: NLM
Infant formula containing bovine milk-derived oligosaccharides supports age-appropriate growth and improves stooling pattern.

Pediatric research

Estorninos E, Lawenko RB, Palestroque E, Lebumfacil J, Marko M, Cercamondi CI.
PMID: 33958719
Pediatr Res. 2021 May 06; doi: 10.1038/s41390-021-01541-3. Epub 2021 May 06.

BACKGROUND: Adding bovine milk-derived oligosaccharides (MOS) enhances the oligosaccharide profile of infant formula. This study aimed to evaluate the safety and efficacy of a MOS-supplemented infant formula.METHODS: In this double-blind randomized controlled trial, healthy infants 21-26 days old were...

Cite
Estorninos E, Lawenko RB, Palestroque E, et al. Infant formula containing bovine milk-derived oligosaccharides supports age-appropriate growth and improves stooling pattern. Pediatr Res. 2021;doi: 10.1038/s41390-021-01541-3.
Estorninos, E., Lawenko, R. B., Palestroque, E., Lebumfacil, J., Marko, M., & Cercamondi, C. I. (2021). Infant formula containing bovine milk-derived oligosaccharides supports age-appropriate growth and improves stooling pattern. Pediatric research, . https://doi.org/10.1038/s41390-021-01541-3
Estorninos, E, et al. "Infant formula containing bovine milk-derived oligosaccharides supports age-appropriate growth and improves stooling pattern." Pediatric research vol. (2021). doi: https://doi.org/10.1038/s41390-021-01541-3
Estorninos E, Lawenko RB, Palestroque E, Lebumfacil J, Marko M, Cercamondi CI. Infant formula containing bovine milk-derived oligosaccharides supports age-appropriate growth and improves stooling pattern. Pediatr Res. 2021 May 06; doi: 10.1038/s41390-021-01541-3. Epub 2021 May 06. PMID: 33958719.
Copy Download .nbib Format: NLM
Evaluation of Gastroesophageal Reflux Disease Using the Bravo Capsule pH System.

Journal of neurogastroenterology and motility

Lawenko RM, Lee YY.
PMID: 26717929
J Neurogastroenterol Motil. 2016 Jan 31;22(1):25-30. doi: 10.5056/jnm15151.

Gastroesophageal reflux disease (GERD) is a disease predominantly seen in the West but there is a rising trend in Asia. Ambulatory 24-hour catheter-based pH monitoring has been the de facto gold standard test for GERD that correlates symptoms with...

Cite
Lawenko RM, Lee YY. Evaluation of Gastroesophageal Reflux Disease Using the Bravo Capsule pH System. J Neurogastroenterol Motil. 2016;22(1):25-30doi: 10.5056/jnm15151.
Lawenko, R. M., & Lee, Y. Y. (2016). Evaluation of Gastroesophageal Reflux Disease Using the Bravo Capsule pH System. Journal of neurogastroenterology and motility, 22(1), 25-30. https://doi.org/10.5056/jnm15151
Lawenko, Rona Marie A, and Lee, Yeong Yeh. "Evaluation of Gastroesophageal Reflux Disease Using the Bravo Capsule pH System." Journal of neurogastroenterology and motility vol. 22,1 (2016): 25-30. doi: https://doi.org/10.5056/jnm15151
Lawenko RM, Lee YY. Evaluation of Gastroesophageal Reflux Disease Using the Bravo Capsule pH System. J Neurogastroenterol Motil. 2016 Jan 31;22(1):25-30. doi: 10.5056/jnm15151. PMID: 26717929; PMCID: PMC4699719.
Copy Download .nbib Format: NLM
Term infant formula supplemented with milk-derived oligosaccharides shifts the gut microbiota closer to that of human milk-fed infants and improves intestinal immune defense: a randomized controlled trial.

The American journal of clinical nutrition

Estorninos E, Lawenko RB, Palestroque E, Sprenger N, Benyacoub J, Kortman GAM, Boekhorst J, Bettler J, Cercamondi CI, Berger B.
PMID: 34617558
Am J Clin Nutr. 2022 Jan 11;115(1):142-153. doi: 10.1093/ajcn/nqab336.

BACKGROUND: Bovine milk-derived oligosaccharides (MOS) containing primarily galacto-oligosaccharides with inherent concentrations of sialylated oligosaccharides can be added to infant formula to enhance the oligosaccharide profile.OBJECTIVE: To investigate the effects of an MOS-supplemented infant formula on gut microbiota and intestinal...

Cite
Estorninos E, Lawenko RB, Palestroque E, et al. Term infant formula supplemented with milk-derived oligosaccharides shifts the gut microbiota closer to that of human milk-fed infants and improves intestinal immune defense: a randomized controlled trial. Am J Clin Nutr. 2022;115(1):142-153doi: 10.1093/ajcn/nqab336.
Estorninos, E., Lawenko, R. B., Palestroque, E., Sprenger, N., Benyacoub, J., Kortman, G. A. M., Boekhorst, J., Bettler, J., Cercamondi, C. I., & Berger, B. (2022). Term infant formula supplemented with milk-derived oligosaccharides shifts the gut microbiota closer to that of human milk-fed infants and improves intestinal immune defense: a randomized controlled trial. The American journal of clinical nutrition, 115(1), 142-153. https://doi.org/10.1093/ajcn/nqab336
Estorninos, Elvira, et al. "Term infant formula supplemented with milk-derived oligosaccharides shifts the gut microbiota closer to that of human milk-fed infants and improves intestinal immune defense: a randomized controlled trial." The American journal of clinical nutrition vol. 115,1 (2022): 142-153. doi: https://doi.org/10.1093/ajcn/nqab336
Estorninos E, Lawenko RB, Palestroque E, Sprenger N, Benyacoub J, Kortman GAM, Boekhorst J, Bettler J, Cercamondi CI, Berger B. Term infant formula supplemented with milk-derived oligosaccharides shifts the gut microbiota closer to that of human milk-fed infants and improves intestinal immune defense: a randomized controlled trial. Am J Clin Nutr. 2022 Jan 11;115(1):142-153. doi: 10.1093/ajcn/nqab336. PMID: 34617558; PMCID: PMC8755036.
Copy Download .nbib Format: NLM
Term infant formula supplemented with milk-derived oligosaccharides shifts the gut microbiota closer to that of human milk-fed infants and improves intestinal immune defense: a randomized controlled trial.

The American journal of clinical nutrition

Estorninos E, Lawenko RB, Palestroque E, Sprenger N, Benyacoub J, Kortman GAM, Boekhorst J, Bettler J, Cercamondi CI, Berger B.
PMID: 34617558
Am J Clin Nutr. 2022 Jan 11;115(1):142-153. doi: 10.1093/ajcn/nqab336.

BACKGROUND: Bovine milk-derived oligosaccharides (MOS) containing primarily galacto-oligosaccharides with inherent concentrations of sialylated oligosaccharides can be added to infant formula to enhance the oligosaccharide profile.OBJECTIVE: To investigate the effects of an MOS-supplemented infant formula on gut microbiota and intestinal...

Cite
Estorninos E, Lawenko RB, Palestroque E, et al. Term infant formula supplemented with milk-derived oligosaccharides shifts the gut microbiota closer to that of human milk-fed infants and improves intestinal immune defense: a randomized controlled trial. Am J Clin Nutr. 2022;115(1):142-153doi: 10.1093/ajcn/nqab336.
Estorninos, E., Lawenko, R. B., Palestroque, E., Sprenger, N., Benyacoub, J., Kortman, G. A. M., Boekhorst, J., Bettler, J., Cercamondi, C. I., & Berger, B. (2022). Term infant formula supplemented with milk-derived oligosaccharides shifts the gut microbiota closer to that of human milk-fed infants and improves intestinal immune defense: a randomized controlled trial. The American journal of clinical nutrition, 115(1), 142-153. https://doi.org/10.1093/ajcn/nqab336
Estorninos, Elvira, et al. "Term infant formula supplemented with milk-derived oligosaccharides shifts the gut microbiota closer to that of human milk-fed infants and improves intestinal immune defense: a randomized controlled trial." The American journal of clinical nutrition vol. 115,1 (2022): 142-153. doi: https://doi.org/10.1093/ajcn/nqab336
Estorninos E, Lawenko RB, Palestroque E, Sprenger N, Benyacoub J, Kortman GAM, Boekhorst J, Bettler J, Cercamondi CI, Berger B. Term infant formula supplemented with milk-derived oligosaccharides shifts the gut microbiota closer to that of human milk-fed infants and improves intestinal immune defense: a randomized controlled trial. Am J Clin Nutr. 2022 Jan 11;115(1):142-153. doi: 10.1093/ajcn/nqab336. PMID: 34617558.
Copy Download .nbib Format: NLM
Term infant formula supplemented with milk-derived oligosaccharides shifts the gut microbiota closer to that of human milk-fed infants and improves intestinal immune defense: A randomized controlled trial.

The American journal of clinical nutrition

Estorninos E, Lawenko RB, Palestroque E, Sprenger N, Benyacoub J, Kortman GAM, Boekhorst J, Bettler J, Cercamondi CI, Berger B.
PMID: 34617558
Am J Clin Nutr. 2021 Oct 07; doi: 10.1093/ajcn/nqab336. Epub 2021 Oct 07.

BACKGROUND: Bovine milk-derived oligosaccharides (MOS) containing primarily galacto-oligosaccharides with inherent levels of sialylated oligosaccharides can be added to infant formula to enhance the oligosaccharide profile.OBJECTIVE: To investigate the effects of a MOS-supplemented infant formula on gut microbiota and intestinal...

Cite
Estorninos E, Lawenko RB, Palestroque E, et al. Term infant formula supplemented with milk-derived oligosaccharides shifts the gut microbiota closer to that of human milk-fed infants and improves intestinal immune defense: A randomized controlled trial. Am J Clin Nutr. 2021;doi: 10.1093/ajcn/nqab336.
Estorninos, E., Lawenko, R. B., Palestroque, E., Sprenger, N., Benyacoub, J., Kortman, G. A. M., Boekhorst, J., Bettler, J., Cercamondi, C. I., & Berger, B. (2021). Term infant formula supplemented with milk-derived oligosaccharides shifts the gut microbiota closer to that of human milk-fed infants and improves intestinal immune defense: A randomized controlled trial. The American journal of clinical nutrition, . https://doi.org/10.1093/ajcn/nqab336
Estorninos, Elvira, et al. "Term infant formula supplemented with milk-derived oligosaccharides shifts the gut microbiota closer to that of human milk-fed infants and improves intestinal immune defense: A randomized controlled trial." The American journal of clinical nutrition vol. (2021). doi: https://doi.org/10.1093/ajcn/nqab336
Estorninos E, Lawenko RB, Palestroque E, Sprenger N, Benyacoub J, Kortman GAM, Boekhorst J, Bettler J, Cercamondi CI, Berger B. Term infant formula supplemented with milk-derived oligosaccharides shifts the gut microbiota closer to that of human milk-fed infants and improves intestinal immune defense: A randomized controlled trial. Am J Clin Nutr. 2021 Oct 07; doi: 10.1093/ajcn/nqab336. Epub 2021 Oct 07. PMID: 34617558.
Copy Download .nbib Format: NLM
Showing 1 to 6 of 6 entries